2'-Deoxy-2'-fluoroguanosine 5'-monophosphate triethyl ammonium

This purine nucleoside analog, 2’-Deoxy-2’-fluoroguanosine 5’-monophosphate triethyl ammonium, demonstrates broad antitumor activity with particular efficacy against indolent lymphoid malignancies. Its primary anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, as supported by research literature. The compound is utilized in biochemical research for studying nucleoside metabolism and in both in vitro and in vivo models of hematological cancers.